David Schomas, MD
Radiation Oncology · Kansas City, MONPI 1811974199
Payments from drug & device makers
Across 33 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$95
- Sanofi$73
- Geron Corporation$59
- Acrotech Biopharma Inc.$53
- Incyte Corporation$40
- Eisai Inc.$39
- plus $367 from 17 others
What the payments were for
- Food & beverage$70397%
- Education$243%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 4 | $95 |
| Sanofi | 2 | $73 |
| Geron Corporation | 1 | $59 |
| Acrotech Biopharma Inc. | 1 | $53 |
| Incyte Corporation | 2 | $40 |
| Eisai Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
| Bayer | 2 | $34 |
| AstraZeneca(2 entities) | 2 | $31 |
| Novartis | 1 | $28 |
| Caris MPI, Inc. | 1 | $27 |
| Johnson & Johnson | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Merck | 1 | $22 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $20 |
| Mirati Therapeutics, Inc. | 1 | $17 |
| Sobi, Inc | 1 | $17 |
| Seagen Inc. | 1 | $16 |
| Varian Medical Systems, Inc. | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Boston Scientific | 1 | $12 |
| Tactile Systems Technology Inc | 1 | $11 |
How this compares
$727 in reported general payments places this provider in the 40th percentile of 123 radiation oncology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $1,726 |
| Dexamethasone | 42 | $681 |
| Oxycodone Hcl | 50 | $625 |
| Lidocaine Hcl ViscousLidocaine Hcl | 15 | $446 |
| Tamsulosin Hcl | 15 | $187 |
| Ondansetron OdtOndansetron | 15 | $172 |
| Prochlorperazine Maleate | 14 | $158 |
| Memantine Hcl | 14 | $86 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Kansas City
- Sunpreet RakhraKansas City$19K
- Yvonne Thanh-Nga PhamKansas City$2K
- Sana KaramSaint Louis$2.7M
- Hiram GaySaint Louis$2M
- Clifford RobinsonSaint Louis$1.5M
- Lauren HenkeSaint Louis$1.2M
- Pamela SamsonSaint Louis$752K
- Jeffrey BradleySaint Louis$712K
- Jeff MichalskiSaint Louis$628K
- Shahed BadiyanSaint Louis$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.